Investor Information

IR banner
Webcast ImageWebcast - Replay
Express Scripts Holding Co at Barclays Global Healthcare Conference 2017
03/15/17 at 9:30 a.m. ET
Express Scripts Holding Co at Barclays Global Healthcare Conference 2017
Wednesday, March 15, 2017 9:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Business Overview

Business Overview
At Express Scripts we believe in practicing pharmacy smarter. We put medicine within reach of tens of millions of people by aligning with our customers, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

Stock chart for: ESRX.O.  Currently trading at $64.11 with a 52 week high of $80.02 and a 52 week low of $63.22.
ESRX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$64.11
Change (%) Stock is Up 0.09 (0.14%)
Volume3,106,266
Data as of 03/24/17 4:00 p.m. ET
Refresh quote
Recent Press Releases
Mango Health Announces Partnership, Strategic Investment from Express Scripts - 03/15/2017 - 12:09 p.m.
New daily health solution connects two industry leading platforms for improving health outcomes and reducing the cost of care.SAN FRANCISCO, March 15, 2017 /PRNewswire-USNewswire/ -- Mango Health, a m... 
Express Scripts Holding Company to Present at the Barclays Global Healthcare Conference - 03/07/2017 - 1:36 p.m.
ST. LOUIS, March 7, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at the Barclays Global Healthcare Conference on Wednesd... 
High Drug Prices Frustrate Government-Sponsored Health Programs, According to New Express Scripts Drug Trend Insights - 02/28/2017 - 5:00 p.m.
ST. LOUIS, Feb. 28, 2017 /PRNewswire/ -- Health plans partnering with Express Scripts are delivering high-quality, affordable pharmacy care to millions of individuals enrolled in government-sponsored ... 
Express Scripts Named one of Fortune Magazine's World's Most Admired Companies of 2017 - 02/16/2017 - 4:12 p.m.
ST. LOUIS, Feb. 16, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) was recognized today by Fortune Magazine as one of the World's Most Admired Companies within the Health Care: Pharmacy and Other... 
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Express Scripts Holding Co posts new information to the site. Just enter your e-mail address and click Submit.
 

Tax Consequences of Express Scripts and Medco Merger

Investor Overview
Learn more about Express Scripts and find corporate and shareholder information.

Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print | E-mail Page E-mail Page | RSS Feeds RSS | E-mail Alerts Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet